Skip to the content

ParValue.app

  • Pusher (*beta)
  • Tables (*beta)
  • News
  • Pusher (*beta)
  • Tables (*beta)
  • News

Tag

#GS

  • 2026

  • BeOne Medicines to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

    26 May
  • Transaction in Own Shares

    26 May
  • Transaction in Own Shares

    22 May
  • Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

    21 May
  • Birkenstock To Execute $250 Million Accelerated Share Repurchase to Take Advantage of Disconnect Between Share Price and Fundamental Performance

    21 May
  • Transaction in Own Shares

    21 May
  • T. ROWE PRICE EXAMINES LEADERSHIP, CULTURE AND THE EVOLVING ROLE OF CAPITAL MARKETS WITH GOLDMAN SACHS CEO DAVID SOLOMON

    20 May
  • Emergent BioSolutions to Participate in Upcoming Investor Conferences

    20 May
  • Transaction in Own Shares

    20 May
  • Umicore – Transparency notifications by The Goldman Sachs Group, Inc.

    19 May
  • Transaction in Own Shares

    19 May
  • Umicore – Transparency notification by The Goldman Sachs Group, Inc.

    18 May
  • Transaction in Own Shares

    18 May
  • Transaction in Own Shares

    15 May
  • Transaction in Own Shares

    14 May
  • Transaction in Own Shares

    13 May
  • Umicore – Transparency notification by The Goldman Sachs Group, Inc.

    12 May
  • Goldman Sachs Alternatives Acquires FGI Worldwide

    12 May
  • Transaction in Own Shares

    12 May
  • Transaction in Own Shares

    11 May
  • Hershey to Participate in Goldman Sachs Global Staples Forum on May 12, 2026

    8 May
  • Transaction in Own Shares

    8 May
  • Aidoc Raises $150 Million Series E Led by Goldman Sachs to Scale Clinical AI for Earlier, Safer Diagnoses

    29 Apr
  • Hightouch Raises $150 Million to Reinvent How Marketing Works Using AI

    29 Apr
  • Goldman Sachs Alternatives Announces Strategic Investment in Kashable, Leading the Company’s Series C Equity Round

    27 Apr

Newer

Older

Privacy policy

Nothing on this site should be in any way construed as investment advice or a recommendation to buy or sell any security. Or do anything whatsoever. Any information posted on the site may be incorrect or incomplete.

Theme by Anders Norén